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he adenomatoid odontogenic tumor (AOT) is a clinically benign lesion. Discussions about the AOT hamartomatous or
neoplastic nature, and the probable odontogenic epithelial cell it originates from still exist. This research aimed to study and
discuss the subject by the immunohistochemical detection of cytokeratins, laminin, collagen IV, PCNA and p53 in 8 tumor
samples and 8 dental follicle samples containing reduced enamel epithelium. The results have shown that CK14 labelling
indicated differentiation grades for secreting ameloblasts or ameloblasts in the post-secreting stage in the adenomatoid
structure of AOT. Laminin, found on the luminal surface of adenomatoid structures, was compatible with the reduced enamel
epithelium during the “protective stage of amelogenesis”. PCNA specifically labelled the spindled areas and peripheral cords
of the AOT, indicating that these areas are responsible for tumor growth. After considerations about pathogenesis, the authors
suggested that the nature of AOT is hamartomatous with histogenesis from the reduced enamel epithelium.
Uniterms: Odontogenic neoplasms; Adenomatoid odontogenic tumor; Immunohistochemistry.
     tumor odontogênico adenomatóide (TOA) é uma lesão clinicamente benigna, cujas discussões acerca de sua natureza
hamartomatosa ou neoplásica, e provável célula epitelial odontogênica de origem ainda existem. Este projeto de pesquisa teve
por objetivo estudar o assunto através da detecção imuno-histoquímica das citoqueratinas, laminina, colágeno IV, PCNA e p53,
utilizando-se para isso 08 amostras do tumor e 08 amostras de folículo pericoronário contendo epitélio reduzido do órgão do
esmalte (EROE). Os resultados mostraram que a marcação da CK14 sinalizou graus de diferenciação para ameloblastos secretores
ou pós-secretores nas estruturas adenomatóides do TOA, e  a laminina presente em sua superfície luminal foi compatível com
o EROE durante o “estágio protetor” da amelogênese. O PCNA marcou especificamente áreas enoveladas e cordões periféricos
do TOA, indicando serem estes os responsáveis pelo seu crescimento. Após considerações sobre patogênese, os autores
propuseram natureza hamartomatosa  e histogênese a partir do EROE para o TOA.
Unitermos: Neoplasias odontogênicas; Tumor odontogênico adenomatóide; Imunoistoquímica.
INTRODUCTION
Originating from dental bud tissues and developing
preferably in the dental follicles, the adenomatoid
odontogenic tumor (AOT) is undoubtedly accepted as a
benign lesion. The issue of its nature being neoplastic or
hamartomatous is still object of diverging opinions,
generally based on clinical observations and little scientific
evidence. Also, there is no consensus regarding the exact
histogenesis of the tumor, with suggestions ranging from
the dental lamina to the enamel organ as a whole.
In 1975, Courtney and Kerr3 believed it was a hamartoma
(developmental abnormality) of remnant odontogenic
epithelium. Carmo and Silva2 (1998) tried to correlate its
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clinical behavior with the cell proliferation rate assessed by
AgNOR histochemistry. Philipsen and Reichart14 (1999)
considered AOT a non-invasive slow-growing benign lesion
(hamartomatous). For Takahashi, et al.19 (2001) transferrin
detection by immunohistochemistry in part of the tumoral
cells indicated a neoplastic nature.
There is no doubt about the AOT origin from the
odontogenic epithelium; however the cell directly involved
in the pathogenesis is still under discussion. Stratum
intermedium cells (Okada, et al.13, 1987; Montes Ledesma, et
al.10, 1993), reduced enamel epithelium (Courtney and Kerr3,
1975), dental lamina and its remains (Philipsen and Reichart15,
1999, Philipsen, et al.16, 1992), enamel organ (Hatakeyama
and Suzuki7, 1978, Schlosnagle and Someren18, 1981),
undifferentiated odontogenic epithelium or stratum
intermedium cells (Tatemoto, et al.22, 1988) were suggested.
Electron microscopy studies have revealed the
interesting presence of hemidesmosomes in the luminal cell
membrane of the duct-like and adenomatoid structures,
connecting it to a basal lamina-like material. Membrane-
covered vesicles and granules, with electron-dense central
portion, were sometimes interpreted as secretion granules
producing intraluminal material (Lee9, 1974; Hatakyama and
Suzuki7, 1978; Schlosnagle and Someren18, 1981; Yamamoto,
et al.24, 1981; Poulson and Greer17, 1983; Philipsen and
Reichart14, 1996).
Few studies in the literature have used the
immunohistochemistry technique to analyze AOTs. The most
relevant ones detected substances related to amelogenesis,
such as enamelysin (Takata, et al.21, 2000), amelogenin
(Murata, et al.11, 2000; Abiko, et al.1, 2001), sheathlin (Takata,
et al.20 2000). Crivelini, et al.4 (1996) described laminin on the
luminal surface of columnar cells outlining the adenomatoid
structures. This finding might resemble the basal lamina
next to the internal and external epithelium of the enamel
organ, or the surface of the reduced enamel epithelium in
the enamel maturation stage. Nagatsuka, et al.12 (2002)
detected five distinct polypeptide chains of type IV collagen
on the eosinophilic hyaline materials.
Based on clinical observations and histochemical,
immunohistochemical and ultrastructural findings in
literature, we have adopted the hypothesis of AOT being a
simple hamartoma, whose histogenesis would be related to
the reduced enamel epithelium. Thus, our proposal was to
establish the participation of the different polypeptides of
cytokeratin, laminin, collagen IV, PCNA, and p53 in the cell
and tissue structures of AOT, and to compare it with their
expression in the reduced enamel epithelium and with the
immunohistochemical reports of the dental buds. This may
give support to discussions about the existing hypothesis
for tumor pathogenesis and biological nature.
MATERIALS AND METHODS
Eight adenomatoid odontogenic tumors and 8 dental
follicles with reduced enamel epithelium were retrieved from
the files of the Oral Pathology Department of the State
University - Araçatuba, Dental School, Brazil.
Paraffin sections of formalin fixed tissue were used for
both histological and immunohistochemical evaluation.
Hematoxylin-eosin stained sections were made for routine
histological examination. For immunohistochemical
technique, 3-µm tissue sections were deparaffinized and
treated with citric acid (10mM, pH 6.0) three times for 5 min.
at 700W in a microwave oven. Two incubations (5 min. each)
with 0.6% hydrogen peroxide in methanol were made in order
to block endogenous peroxidase activity, followed by
washing with TRIS pH 7.4. Primary antibodies were then
incubated; their sources, concentrations, and times of
incubation are listed in Table 1. After this procedure, sections
were thoroughly washed with TRIS pH 7.4 and incubated
for 20 min. using Universal Large Volume DAKO LSAB®+
Kit, a biotinylated link antibody that labels primary antibodies
produced in rabbit, mouse or goat. The color reaction was
developed using a freshly prepared solution of 3,3-
diaminobenzidine tetrahydrochloride for 3 min. Finally
Mayer’s hematoxylin was used for counterstaining. Data
were scored by observing the presence of a brown end
product at the site of the target antigen under a light
microscope. Positive controls for each CK and vimentin were
used as indicated by the supplier, which labelled, in normal
tissues, the following: CK7, 18, 19 (glandular epithelia), CK
10, 13 (suprabasal cells of epidermis), CK 14 (basal cells of
epidermis), and vimentin (endothelial cells). Replacing the
primary antibody with TRIS performed negative controls.
RESULTS
Tables 2 and 3 summarize the immunohistochemical
results obtained using paraffin sections of formalin fixed
tissue.
Adenomatoid odontogenic tumor
The adenomatoid odontogenic tumors presented
epithelial proliferation in which cells placed in solid nodules
forming sheets, or a nest-and cord-like pattern. In the solid
nodules, cells were ovoid and cylindrical, the latter outlining
duct-like structures, which contained homogeneous
eosinophilic material in the center. Sometimes the
eosinophilic material showed linear configuration, also
outlined by cylindrical cells. Adenomatoid structures were
generally present, which were round with a much wider
diameter than the duct-like structures and outlined by low
or tall columnar cells. Not rarely did these structures present
a thin layer of the eosinophilic material in its internal surface.
Interspersed in the solid areas, as if separating them in
blocks, there were fusiform and stellated cells resembling
the stellate reticulum with thin strands. Small cuboid or
polyhedrical cells formed peripheral cords that sometimes
seemed to fold and overlap, forming compact sheets. In one
of the tumors, occasional cell foci with a squamous
appearance were observed. Mineralized structures
resembling Liesegang rings, dystrophic calcification areas,
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and other small intercellular eosinophilic hyaline deposition,
with shapeless light or dark pinkish appearance, sometimes
lamellar and concentric were present. Adjacent to the tumoral
proliferation, a cystic lining formed by stratified pavement
epithelium was common. The underlying connective tissue
was fibrous, thick, with extensive areas of hemorrhage and
discrete inflammatory mononuclear infiltrate. In the vicinities
of the tumor, blood capillary vessels with perivascular
hyalinization, and delicate connective tissue rich in ground
substance were noted.
In the immunohistochemical staining, tumoral epithelial
cells were not positive for cytokeratins 7, 13, 18, 19, vimentin
and p53. CK14 was detected in the cords of cubic and
peripheral polyhedrical cells, as well as in the fusiform and
stellated cells adjacent to the solid areas of the tumor. Cells
forming the adenomatoid structures and the solid areas were
not positive in two of the samples and varied in the others
(Figure 1).  An expression pattern opposite to CK14 was
observed in the detection of PCNA. It labelled, from weakly
to strongly, most of the cells in the solid areas, adenomatoid
structures, cords of cubic and polyhedrical cells, and was
practically absent or weak in the fusiform cells and in the
stellated cells interspersed in the solid areas (Figure 2).
The immunohistochemical analysis showed positive
results for laminin in the luminal surface of the cells bordering
the adenomatoid structures, in the small intercellular
deposits of lighter eosinophilic material interspersed in the
epithelial proliferation of spindled areas and cords, and on
the borders between the tumor and connective tissue (Figure
3). The material corresponding to darker eosinophilc was
negative for laminin.  Collagen IV had discrete expression
only in the zone of the basal membrane of a few tumors;
however, around the neighboring stromal capillary vessels
it was noteworthy.
Reduced enamel epithelium
The samples of pericoronal flap presented pavement
stratified reduced enamel epithelium, with two or three cell
layers and, in one of the samples, cubic basal cells and
columnar superficial cells, resembling post-secretory
ameloblasts.
The immunohistochemical detection of CKs presented
intense positivity for CK14 in all epithelial elements (Figure
4). The expression was variable for CK13, labelling
occasional disperse cells, generally superficial (Figure 5).
Weak expression in this same pattern characterized CK19,
in three samples. The results for CK7, 18, vimentin, and p53
were negative. Laminin was clearly expressed in the zone of
the basal membrane, both of the epithelium and of the blood
vessels, a pattern that was followed by collagen IV; however,
with weaker expression, not rarely absent next to the
epithelium. PCNA was expressed mainly in the basal epithelial
cell nuclei and in some of the suprabasal cells. The epithelium
with columnar cells followed this pattern, with rare positive
suprabasal cells (Figure 6). Epithelia in inflammatory areas
presented disperse positivity.
DISCUSSION
As previously said, we focused on the ultrastructural
detail of the presence, in the luminal surfaces of the
adenomatoid structures, of hemidesmosomes and a material
similar to the basal lamina, confirmed histochemically by
the presence of laminin. Such characteristics are similar to
those of the reduced enamel epithelium (REE) in the
protective and maturation stage of amelogenesis, which led
us to work on the hypothesis of the origin of AOT from it. It
is known that at the end of amelogenesis, post-secretory
ameloblasts synthesize a material similar to the basal lamina,
which adheres to the newly formed enamel. This stage is
called “protective stage of amelogenesis”, which avoids
cementoblastic differentiation in the follicle and cementum
deposition (or “osteodentin”) next to the enamel (Ten Cate23,
1994).
This would justify the capability of AOT cells to secrete
enamel matrix proteins, such as amelogenin or enamelin
shown in the immunohistochemical reactions of Murata, et
al.11 (2000). We can consider in our hypothesis of AOT origin
Antibodies Clone Concentration Incubation time (min) Temperature
CK7a OV-TL 12/30 1:150 60 room
CK10-13a DE-K13 1:150 60 room
CK14a LL002 1:500 60 room
CK18a DC10 1:50 60 room
CK19a RCK108 1:75 60 room
Vimentina VIM3B4 1:300 60 room
Lamininb LAM-89 1:200 120 room
Collagen IVa CIV 22 1:100 120 room
PCNAa PC10 1:300 120 room
p53a DO-7 1:75 60 room
TABLE 1- Monoclonal antibodies used
aDako Corporation; bNovocastra Laboratories Ltd
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from the REE that the cells in that epithelium had been recently
active, producing enamel matrix in the amelogenesis and
that some of them might still keep the capacity of synthesis
and secretion when forming the AOT. Corroborating this
idea is the known influence of the REE on the modifications
in the composition of enamel after amelogenesis, in normal
conditions, which does not play only the protective role
(Ten Cate23, 1994). We believe that AOT cells might be able
to secrete two types of substances, according to their
functional capability: basal membrane material or enamel
FIGURE 1- Adenomatoid odontogenic tumor: CK 14
citoplasmic positivity only in the fusiform and stellated cells
(arrow) adjacent to the solid nodules (A). X400
FIGURE 2- Adenomatoid odontogenic tumor: strong nuclear
expression of PCNA restricted at solid areas (arrows),
oppositing CK14 results. X400
FIGURE 3- Adenomatoid odontogenic tumor: laminin in the
intercellular deposits and luminal surface of adenomatoid
structures. X200
FIGURE 4- Reduced enamel epithelium: All cells exhibiting
CK14. X400
FIGURE 5-Reduced enamel epithelium:  Detection of CK13
in disperse cells (arrow). X400
FIGURE 6- Reduced enamel epithelium: nuclei of basal
cells darker due to PCNA expression. X400
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matrix. The distinction between these two substances in
the routine hematoxylin and eosin staining is possible. We
described in our results the presence of eosinophilic material
in small intercellular deposits, with a shapeless pinkish aspect
either lighter or darker, sometimes lamellar, both disperse in
the epithelial sheets of the AOT. The former was
immunohistochemically positive for laminin, therefore,
representing substance of the basal membrane. The latter
did not express laminin and apparently was prone to
mineralization, and probably corresponded to the material
positive to enamel protein in the study of Takata, et al.20,21
(2000).
As the AOT is an epithelial tumor, it is interesting to
analyze histochemically the different types of cytokeratins
in it. Domingues, et al.6 (2000) described the distribution of
the subtypes of intermediate filaments in the dental buds.
They emphasised CK 14 present in the inner epithelium of
the enamel organ in the early bell stage, which was
posteriorly substituted by CK19, when the ameloblasts were
completely differentiated. We had an interesting CK14
immunohistochemical profile. In some of the samples, it
labelled only cells between the spindled and duct-like
structures, distinguishing two cell populations. The spindled
areas and the cylindrical cells of the duct-like structures did
not express it. So, the variation in the expression of CK14
indicated variable differentiations of the tumoral cells. The
spindled structures, where the duct-like and adenomatoid
structures were located, would form a cell group analogous
to post-secretory ameloblasts of the reduced enamel
epithelium, surrounded by a second group, constituted by
flat fusiform cells, sometimes with morphology similar to
that of the stellate reticulum. If we consider the cubic cells
of the duct-like and adenomatoid structures analogous to
post-secretory ameloblasts in their early stage, still capable
Antibodies CK7  CK13    CK14 CK18    CK19 Vimentin Laminin Collagen IV PCNA   p53
Histological
structure
Solid nodules - - +/- - -  - -   -     + -
Duct-like structures - - +/- - -  - -   -     + -
Adenomatoid structures - - +/- - -  - -   -     + -
Flatted and stellated cells - - + - -  - -   -      - -
Peripheral cords of cubic
or polyhedrical epithelial cells - - + - -  - -   -      - -
Lighter homogeneous
eosinophilic material - - - - -  - +   -      - -
Darker homogeneous
eosinophilic material - - - - -  - -   -      - -
Calcified bodies - - - - -  - -   -      - -
Basal lamina - - - - -  - +   +      - -
TABLE 2- Immunohistochemical staining of epithelial components of adenomatoid odontogenic tumor by monoclonal
antibodies directed against different substances
+, positive; -, negative; +/-, weak positive
Antibodies CK7  CK13    CK14 CK18    CK19 Vimentin Laminin Collagen IV PCNA   p53
Histological
structure
Cylindrical upper cells -     +* +    - +/-* - -   -   +** -
Squamous cells -     +* +    - +/-* - -   -   +** -
Basal cells -     +* +    - +/-* - -   -   + -
Basal lamina -      - -    -   - - +   +    - -
*Occasional and disperse cells; **rare cells (+, positive; -, negative; +/-, weak positive)
TABLE 3- Immunohistochemical staining of reduced enamel epithelium of dental follicles by monoclonal antibodies directed
against different substances
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of secreting some enamel protein, the tendency for absence
of CK14 is understandable because this also occurred in
normal ameloblasts. From the moment at which the cells no
longer have their secretory function, CK14 is expressed
again. This justifies the expression in all epithelial cell
elements of other AOTs and in the REE, regardless of the
histological characteristics.
Laminin was clearly present in the luminal surface of the
adenomatoid structures and in the lighter eosinophilic
intercellular deposits, either focal or linear, which is
compatible with the surface of the reduced enamel epithelium
during the protective stage of amelogenesis. Nevertheless,
in our REE samples, laminin was not detected in the epithelial
surface, probably because the REE in the samples are
associated to dentigerous cyst, which would modify its
expression. Type IV collagen was restricted to the interface
between tumor epithelium and stroma. Nagatsuka, et al.12
(2002) obtained analogous results with α1(IV)/α2(IV) and
α5(IV)/α6(IV) polypeptide chains of type IV collagen.
Nevertheless, the authors believed that some cells of AOT
(cribriform areas) would resemble dental lamina (primitive
cells), while others would be histodifferentially more mature
(secretory phase of odontogenesis), due to α4(IV) chain
expression had ocurred on the cribriform areas and hyaline
materials.
PCNA results in the REE were as expected, with
expression restrict to the basal or suprabasal cells or cells
scattered in areas in which subepithelial inflammation was
present.  In the AOT, PCNA revealed that the cells in the
spindled areas and in the peripheral cords were the most
proliferative, which could suggest that those sites would
be responsible for the tumoral growth. We could justify the
absence of the typical adenomatoid structures in the solid
nodules forming sheets because they could have
disappeared for having been gradually compressed by the
tumoral mass as it evolved. The large adenomatoid
structures, resulting from the circular (tridimensional,
“tubular”) configuration of the columnar cells and cylindrical
superficial cells of the REE due to its hamartomatous growth,
would be formed in recent tumors, right from their onset.
They would gradually decrease, however, due to
compression of the tumoral mass as it grew. The specific
PCNA cell labelling in the AOTs, not present in the flat and
stellate cells among the spindled areas, helped to rule out a
neoplastic nature for the tumor.
As far as the extrafollicular variant, we agree with
Philipsen, et al.16 (1992) concerning the possibility of a tooth
erupting through the AOT. The hamartomatous lesion would
start at the REE and occasionally would not hinder dental
eruption. We would also emphasize that the AOT could
remain intraosseous or peripheral in the jaw bones,
depending on the spatial position of the tumor and
associated tooth. In deeper impacted teeth, there would be
more possibility of TOA to be intraosseous follicular or
extrafollicular (in the case of tooth eruption) lesion. In tooth
impactions next to the alveolar ridge, the tumor could
occasionally involve the gingiva during or after the eruption
process, which would justify the peripheral variant.
The interesting dysplastic dentin microscopic picture
has led the World Health Organization (WHO) to classify
the AOT in the group of neoplasias and other tumors related
to the odontogenic apparatus, benign subgroup composed
by odontogenic epithelium with ectomesenchyme in the
Histological Typing of Odontogenic Tumors (Kramer, et al.8,
1992). We could accept the rare formation of osteodentin
next to the AOT, but as secondary phenomenon in the tumor
pathogenesis. If we had previously considered that the AOT
produces enamel matrix in some areas, this matrix, when in
contact with stromal connective tissue, would trigger
mesenchymal induction in the same way as the phenomenon
reported by Ten Cate23 (1994) in the “protective stage of
amelogenesis”, in which there is osteodentin or cementum
production on the enamel surface by differentiation of dental
follicle cells. With these arguments, we discuss if it wouldn’t
be better to classify AOT as “neoplasias and other tumors
related to the odontogenic apparatus, benign subgroup
composed by odontogenic epithelium without odontogenic
ectomesenchyme”.
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